Medical device company Alphatec Holdings (ATEC) has signed an agreement to acquire Paris-based EOS imaging.

The deal, a combination of cash and equity, includes a purchase price of up to $88m and debt retirement of $33.9m.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

EOS designs orthopaedic medical imaging and software solutions. The company is known for its low dose, biplanar full-body imaging and 3D modelling capabilities.

EOS’ product portfolio includes spineEOS, an online 3D planning software for spine surgery approved by US Food and Drug Administration (FDA).

ATEC chairman and CEO Pat Miles said: “This is a monumental transaction for ATEC. While spine’s large players are investing in enabling technologies, we are thinking differently. We created a conduit to deliver information into the operating room with AlphaInformatiX.

“This transaction will integrate spine imaging and anatomical modelling onto the platform to actually inform the operative experience. By pairing ATEC’s approach-based solutions with imaging founded on Nobel Prize-winning technology, we expect to significantly increase demand for ATEC hardware and EOS systems and create a formidable competitive advantage.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

With the addition of EOS imaging, ATEC’s AlphaInformatiX platform’s delivering capabilities will boost in patient-specific implants, surgical planning, intraoperative alignment reconciliation, and other intraoperative functionalities.

The transaction is expected to be accretive to ATEC’s revenue growth, as well as create cross-selling opportunities due to the expanded customer base and sales network.

Under the agreement, EOS’s shareholders will receive approximately $3.08 per EOS share under the cash offer or 0.50 ATEC common shares per the EOS share under the exchange offer.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact